Capauto, Davide
Wang, Yifan
Wu, Feinan
Norton, Scott
Mariani, Jessica
Inoue, Fumitaka
Crawford, Gregory E.
Ahituv, Nadav
Abyzov, Alexej
Vaccarino, Flora M.
Funding for this research was provided by:
National Institute of Mental Health (R56 MH114901, U01 MH116438, R56 MH114899, R01 MH109648)
Simons Foundation (632742)
Article History
Received: 8 September 2023
Accepted: 11 February 2024
First Online: 16 February 2024
Competing interests
: NA is the cofounder and on the scientific advisory board of Regel Therapeutics and receives funding from BioMarin Pharmaceutical Incorporated. All other authors do not hold any competing interest.